BioNTech Highlights African Vaccine Partnerships – But is Challenged to Ensure Real Tech Transfer 18/10/2023 Vijay Shankar Balakrishnan BERLIN – German mRNA vaccine maker BioNTech’s partnerships with vaccine manufacturing facilities in Rwanda, Senegal and South Africa will support the African Union’s ambition to produce 60% of the continent’s vaccine needs by 2040, the company told the World Health Summit. But Ayaode Alakija, former Chief Humanitarian Coordinator for Nigeria and World Health Summit Ambassador, […] Continue reading -> Pandemic Accord Negotiators Are ‘Cautiously Optimistic’ 16/10/2023 Vijay Shankar Balakrishnan BERLIN – Negotiations to produce a pandemic agreement still face a number of challenges, but some of the key negotiators in the International Negotiating Body (INB) told the World Health Summit that they are cautiously optimistic. As protestors gathered outside the summit venue, the JW Mariott Hotel in Berlin, to express their distrust of the […] Continue reading -> WHO Pandemic Treaty: The Good, The Bad, & The Ugly – An Interview With Larry Gostin 14/09/2023 Vijay Shankar Balakrishnan Lawrence O. Gostin is “confident” that countries will adopt a pandemic accord at the 2024 World Health Assembly. The question is whether it will include the kind of “robust norms” necessary to ensure that the new accord is “transformative” with respect to correcting disparities and injustices uncovered in the last pandemic, and effective in its […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pandemic Accord Negotiators Are ‘Cautiously Optimistic’ 16/10/2023 Vijay Shankar Balakrishnan BERLIN – Negotiations to produce a pandemic agreement still face a number of challenges, but some of the key negotiators in the International Negotiating Body (INB) told the World Health Summit that they are cautiously optimistic. As protestors gathered outside the summit venue, the JW Mariott Hotel in Berlin, to express their distrust of the […] Continue reading -> WHO Pandemic Treaty: The Good, The Bad, & The Ugly – An Interview With Larry Gostin 14/09/2023 Vijay Shankar Balakrishnan Lawrence O. Gostin is “confident” that countries will adopt a pandemic accord at the 2024 World Health Assembly. The question is whether it will include the kind of “robust norms” necessary to ensure that the new accord is “transformative” with respect to correcting disparities and injustices uncovered in the last pandemic, and effective in its […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Pandemic Treaty: The Good, The Bad, & The Ugly – An Interview With Larry Gostin 14/09/2023 Vijay Shankar Balakrishnan Lawrence O. Gostin is “confident” that countries will adopt a pandemic accord at the 2024 World Health Assembly. The question is whether it will include the kind of “robust norms” necessary to ensure that the new accord is “transformative” with respect to correcting disparities and injustices uncovered in the last pandemic, and effective in its […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading ->